Breast Implants Global Market Report 2024

Breast implants, designed as breast-shaped pouches with a silicone outer shell and filled with either silicone gel or saline, are utilized to alter the size, shape, and appearance of the breasts.

Key categories of breast implants include silicone implants, form-stable implants, saline implants, and structured saline implants. Silicone implants, filled with silicone gel that closely mimics natural breast tissue, are employed in breast augmentation and breast reconstruction procedures. These products are utilized by various end-users, including hospitals, cosmetology clinics, and other establishments involved in cosmetic and reconstructive surgery.

The breast implants market research report is one of a series of new reports that provides breast implants market statistics, including breast implants industry global market size, regional shares, competitors with a breast implants market share, detailed breast implants market segments, market trends and opportunities, and any further data you may need to thrive in the breast implants industry. This breast implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The breast implants market size has grown strongly in recent years. It will grow from $2.48 billion in 2023 to $2.69 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth observed during the historical period can be attributed to several factors, including the expansion of beauty and cosmetic surgery, heightened awareness of breast cancer, an increased demand for minimally invasive breast augmentation procedures, evolving aesthetic preferences and body image perceptions, and the growth of medical tourism alongside the globalization of plastic surgery.

The breast implants market size is expected to see strong growth in the next few years. It will grow to $3.7 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The anticipated growth in the forecast period can be attributed to an increasing emphasis on personalized breast augmentation solutions, the expanding applications of breast implants in transgender and gender confirmation surgery, market expansion in emerging economies, growing societal acceptance of cosmetic procedures, and a heightened emphasis on achieving natural-looking results with reduced complications. Key trends expected during this period include the adoption of sustainability and eco-friendly implants, the prioritization of patient-centric healthcare, the integration of telemedicine and virtual consultations, the popularity of fat transfer procedures, and a rise in combination procedures for enhanced outcomes.

The breast implants market is experiencing growth due to several factors, with a significant contribution from the rising incidence of breast cancer. Breast cancer surgery is a crucial aspect of breast cancer treatment, often involving the removal of breast tissue or lymph nodes. After such surgeries, breast implants are used by patients to restore the breast's shape and size, aiding in the recovery of a natural body appearance. The American Cancer Society reported around 297,790 new cases of invasive breast cancer in women in 2023, underscoring the increasing prevalence of this condition. This trend is anticipated to drive the growth of the breast implants market as more individuals opt for breast reconstruction procedures.

Government initiatives focused on research and development in healthcare are expected to further propel the breast implants market. Governments are increasingly investing in healthcare initiatives to support various aspects of medical research, including breast implants. For example, the UK government committed £260 million (approximately US $270.65 million) in funding to boost healthcare research and manufacturing in 2022. This funding aims to support NHS-led health research, develop diagnostics and treatments, and expand life sciences manufacturing in the UK. Such initiatives create a conducive environment for advancements in breast implant technologies.

In response to market demands, major companies operating in the breast implants sector are developing next-generation products to gain a competitive edge. An example is GC Aesthetics, an Ireland-based surgical company that launched PERLE, the next-generation breast implant, in May 2021. PERLE implants are designed to provide a more natural look and feel, offering a range of sizes and shapes to cater to individual patient needs. The rapid market adoption of innovations like PERLE indicates a growing demand for advanced breast implants that meet the requirements of both surgeons and patients. These developments collectively contribute to the ongoing expansion of the breast implants market.

The breast implants market is witnessing innovative developments from major companies, contributing to its growth. For example, Sientra, a US-based breast implant manufacturer, launched high-strength cohesive silicone gel breast implants in Canada in July 2023. This introduction represents a significant milestone for Sientra and underscores the company's commitment to delivering innovative and high-quality medical devices for plastic and reconstructive surgery. The new breast implants aim to provide a more natural look and feel, featuring clinically proven low complication rates. Sientra's entry into the Canadian market with these implants reflects its dedication to expanding its global presence and meeting the diverse needs of patients and healthcare professionals.

Integra LifeSciences, a US-based science company, made a strategic move in December 2022 by acquiring Surgical Innovation Associates (SIA) for $50 million. This acquisition is expected to advance Integra's global strategy in breast reconstruction and enhance its access to the US market with FDA-approved devices for implant-based breast reconstruction (IBBR) procedures. Surgical Innovation Associates (SIA), a US-based company specializing in breast implants, brings valuable expertise and products to Integra LifeSciences, strengthening its position in the breast implants market.

Major companies operating in the breast implants market include Sientra Inc., GC Aesthetics PLC, HansBiomed Corp., Establishment Labs Holdings Inc., Silimed Indústria de Implantes Ltda., Ideal Implant Incorporated, Polytech Health & Aesthetics GmbH, Sebbin SAS, Establishment Labs S.A., Surgiform Technology Ltd., Johnson & Johnson, Guangzhou Wanhe Plastic Materials Co. Ltd., Hans Biomed Co. Ltd., G&G Biotechnology Ltd., Groupe SEBBIN SAS, Mentor Worldwide LLC, Arion Laboratories LLC, Hans Biomed Corp., Actavis PLC, Nagor Limited, Lattice Medical, Motiva Implants, RTI Surgical Holdings Inc., Shanghai Kangning Medical Supplies Ltd., Thinkers Enterprise Co. Ltd., Adoderm GmbH, WestPac Surgical LLC, AirXpanders Inc., Koken Co. Ltd., Groupe Brochard

North America was the largest region in the breast implants market in 2023. The regions covered in the breast implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the breast implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The breast implants market consists of sales of Saline-Filled Breast Implants, Silicone-Filled Breast Implants, and Breast Tissue Expanders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.